The pathogenesis of celiac disease

Shewry, 1995, Seed storage proteins: structures and biosynthesis, Plant Cell, 7, 945, 10.1105/tpc.7.7.945 van de Kamer, 1953, Coeliac disease IV. An investigation into the injurious constituents of wheat in connection with their action on patients with coeliac disease, Acta Paediatr, 42, 223, 10.1111/j.1651-2227.1953.tb05586.x Zohary, 1993 Janatuinen, 1995, A comparison of diets with and without oats in adults with celiac disease, N Engl J Med, 333, 1033, 10.1056/NEJM199510193331602 Ciclitira, 1984, Clinical testing of gliadin fractions in coeliac patients, Clin Sci, 66, 357, 10.1042/cs0660357 Cornell, 1996, Coeliac disease: a review of the causative agents and their possible mechanism of action, Amino Acids, 10, 1, 10.1007/BF00806090 Marsh, 1983, Enterocytes, immunocytes, and the lamina propria—an immunologic framework of coeliac disease, J R Coll Physicians Lond, 17, 205 Sollid, 1993, HLA susceptibility genes in celiac disease: genetic mapping and role in pathogenesis, Gastroenterology, 105, 910, 10.1016/0016-5085(93)90912-V Gjertsen, 1994, T cells recognize a peptide derived from alpha-gliadin presented by the celiac disease–associated HLA-DQ (alpha 1*0501, beta 1*0201) heterodimer, Hum Immunol, 39, 243, 10.1016/0198-8859(94)90267-4 Franco, 1994, Peripheral T cell response to A-gliadin in celiac disease: differential processing and presentation capacities of Epstein-Barr–transformed B cells and fibroblasts, Clin Immunol Immunopathol, 71, 75, 10.1006/clin.1994.1054 Hill, 1992, Molecular analysis of the association of HLA-B53 and resistance to severe malaria, Nature, 360, 434, 10.1038/360434a0 Rammensee, 1995, MHC ligands and peptide motifs: first listing, Immunogenetics, 41, 178, 10.1007/BF00172063 Johansen, 1996, Identification of a putative motif for binding of peptides to HLA-DQ2, Int Immunol, 8, 177, 10.1093/intimm/8.2.177 Godkin, 1997, Use of eluted peptide sequence data to identify the binding characteristics of peptides to the insulin-dependent diabetes susceptibility allele HLA-DQ8 (DQ 3.2), Int Immunol, 9, 905, 10.1093/intimm/9.6.905 Maiuri, 1996, Definition of the initial immunological modifications upon in vitro gliadin challenge in the small intestine of celiac patients, Gastroenterology, 110, 1368, 10.1053/gast.1996.v110.pm8613040 Picarelli, 1996, Gluten-sensitive disease with mild enteropathy, Gastroenterology, 111, 608, 10.1053/gast.1996.v111.pm8780564 Kleijmeer, 1995, MHC class II compartments and the kinetics of antigen presentation in activated mouse spleen dendritic cells, J Immunol, 154, 5715, 10.4049/jimmunol.154.11.5715 Zhong, 1996, An autosomal screen for genes that predispose to celiac disease in the western counties of Ireland, Nat Genet, 14, 329, 10.1038/ng1196-329 Pena, 1978, Genetic basis of gluten-sensitive enteropathy, Gastroenterology, 75, 230, 10.1016/0016-5085(78)90408-0 Houlston, 1996, Genetics of coeliac disease, Q J Med, 89, 737, 10.1093/qjmed/89.10.737 1995, Coeliac disease, 9 de Ritis, 1988, In vitro (organ culture) studies of the toxicity of specific A-gliadin peptides in celiac disease, Gastroenterology, 94, 41, 10.1016/0016-5085(88)90607-5 Sturgess, 1994, Wheat peptide challenge in coeliac disease, Lancet, 343, 758, 10.1016/S0140-6736(94)91837-6 Matzinger, 1994, Tolerance, danger and the extended family, Annu Rev Immunol, 12, 991, 10.1146/annurev.iy.12.040194.005015 Mantzaris, 1991, In vivo toxicity of a synthetic dodecapeptide from A gliadin in patients with coeliac disease, Scand J Gastroenterol, 26, 392, 10.3109/00365529108996500 Dieterich, 1997, Identification of tissue transglutaminase as the autoantigen of celiac disease, Nat Med, 3, 797, 10.1038/nm0797-797